|
|
|
|
| LEADER |
04152nma a2201189 u 4500 |
| 001 |
EB002051057 |
| 003 |
EBX01000000000000001194723 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
220822 ||| eng |
| 020 |
|
|
|a 9783036545424
|
| 020 |
|
|
|a books978-3-0365-4541-7
|
| 020 |
|
|
|a 9783036545417
|
| 100 |
1 |
|
|a Costanzi, Marco
|
| 245 |
0 |
0 |
|a Predicting Psychopathological Onset: Early Signs of Neuropsychiatric Diseases
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2022
|
| 300 |
|
|
|a 1 electronic resource (242 p.)
|
| 653 |
|
|
|a mentalization
|
| 653 |
|
|
|a FreeSurfer
|
| 653 |
|
|
|a emotional eating
|
| 653 |
|
|
|a depressive disorders
|
| 653 |
|
|
|a neurovisceral integration model
|
| 653 |
|
|
|a psychopathologies
|
| 653 |
|
|
|a bipolar disorders
|
| 653 |
|
|
|a aging
|
| 653 |
|
|
|a COVID-19 vaccine
|
| 653 |
|
|
|a psychological distress
|
| 653 |
|
|
|a depression
|
| 653 |
|
|
|a prefrontal functions
|
| 653 |
|
|
|a heart rate variability
|
| 653 |
|
|
|a epidemiological survey
|
| 653 |
|
|
|a screening
|
| 653 |
|
|
|a bipolar disorder
|
| 653 |
|
|
|a affective disorder
|
| 653 |
|
|
|a assessment
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a cognitive decline
|
| 653 |
|
|
|a diadochokinesia
|
| 653 |
|
|
|a nomogram
|
| 653 |
|
|
|a exercise addiction
|
| 653 |
|
|
|a time perception
|
| 653 |
|
|
|a neuroanatomy
|
| 653 |
|
|
|a adolescence
|
| 653 |
|
|
|a emotional regulation
|
| 653 |
|
|
|a fatherhood
|
| 653 |
|
|
|a body image
|
| 653 |
|
|
|a multiple risk factors
|
| 653 |
|
|
|a euthymic patients
|
| 653 |
|
|
|a genetic variants
|
| 653 |
|
|
|a neurotransmitter system
|
| 653 |
|
|
|a microbiota
|
| 653 |
|
|
|a children
|
| 653 |
|
|
|a recognition memory
|
| 653 |
|
|
|a Pharmacology / bicssc
|
| 653 |
|
|
|a gender
|
| 653 |
|
|
|a sensory motor performance
|
| 653 |
|
|
|a COVID-19
|
| 653 |
|
|
|a vaccine intention
|
| 653 |
|
|
|a polyvagal theory
|
| 653 |
|
|
|a motor control
|
| 653 |
|
|
|a emotional dysregulation
|
| 653 |
|
|
|a Autism Spectrum Disorders (ASD)
|
| 653 |
|
|
|a frequency data
|
| 653 |
|
|
|a self-esteem
|
| 653 |
|
|
|a affective temperaments
|
| 653 |
|
|
|a childhood apraxia of speech
|
| 653 |
|
|
|a perinatal period
|
| 653 |
|
|
|a psychopathology
|
| 653 |
|
|
|a vaccine acceptance
|
| 653 |
|
|
|a forgetting
|
| 653 |
|
|
|a attachment
|
| 653 |
|
|
|a criminal behaviour
|
| 653 |
|
|
|a multilevel model
|
| 653 |
|
|
|a Attentional Boost Effect
|
| 653 |
|
|
|a TMAU
|
| 653 |
|
|
|a social isolation
|
| 653 |
|
|
|a self-report measure
|
| 653 |
|
|
|a Magnetic Resonance Imaging (MRI)
|
| 653 |
|
|
|a alexithymia
|
| 653 |
|
|
|a classification
|
| 653 |
|
|
|a gambling disorder
|
| 653 |
|
|
|a prevention
|
| 653 |
|
|
|a patient health questionnaire
|
| 653 |
|
|
|a psychiatric disorders
|
| 653 |
|
|
|a high-risk group
|
| 653 |
|
|
|a young adults
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a youth
|
| 653 |
|
|
|a friend and family interview
|
| 653 |
|
|
|a integration
|
| 653 |
|
|
|a cerebellum
|
| 700 |
1 |
|
|a Costanzi, Marco
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-4541-7
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/87524
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/5722
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 615
|
| 082 |
0 |
|
|a 700
|
| 520 |
|
|
|a The aim of this Special Issue is to collect valuable contributions from scientists worldwide working on the role that biological, behavioral, and cognitive markers can have in predicting the onset of neuropsychiatric disorders. We were able to collect 13 original articles and two reviews on this topic. The results published in this Special Issue could provide significant support in pre-clinical phases for the identification of vulnerability factors, to better understand the course of the illness, and to predict its outcome, as well as aiding clinicians in the therapeutic decision-making process.
|